From July 1, 2022 to December 31, 2022, the company has repurchased 676,994 shares, representing 0.21% for CNY 43.31 million. With this, the company has completed the repurchase of 1,436,614 shares, representing 0.45% for CNY 98.02 million under the buyback announced on February 7, 2022.
Qingdao Haier Biomedical Co.,Ltd
Equities
688139
CNE100003P25
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
36.88 CNY | -1.02% | -0.19% | -8.98% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.98% | 1.62B | |
+8.06% | 219B | |
+6.94% | 183B | |
+13.54% | 136B | |
-0.27% | 63.07B | |
+11.59% | 51.28B | |
+7.76% | 52.55B | |
+1.14% | 41.21B | |
+3.21% | 36.43B | |
+26.11% | 31.87B |
- Stock Market
- Equities
- 688139 Stock
- News Qingdao Haier Biomedical Co.,Ltd
- Tranche Update on Qingdao Haier Biomedical Co., Ltd's Equity Buyback Plan announced on February 7, 2022.